Flick ??https://www.bbc.co.uk/news/articles/cjd9z0p27k5o
A clinical trial assessing the risks and benefits of puberty-blocking drugs in children who question their gender has been paused after safety concerns were raised by the UK medicines watchdog.
The Medicines and Healthcare Products Regulatory Agency (MHRA) is set to hold talks with King's College London, whose researchers are leading the trial, next week to address concerns, the government said. […]
the MHRA has suggested the minimum age limit of those taking part should be increased to 14, and that there should be more detailed monitoring of bone density and a more rigorous consent process for participants.
All GNU social JP content and data are available under the